MarketPeel
Insider Trading Intelligence
Pricing
…
KK

Kim Kelderman

TECH
PRES. DIAGNOSTICS & GENOM · BIO-TECHNE CORP · CIK 0001739054
FILING MIX · LIFETIME54%/46%
BUYS
47
SELLS
40
TOTAL VALUE
$19.91M
COMPANIES
2
ACTIVE SINCE
May 2020
HOLDINGS NOW
95,522
AVG SELL PX
$74.30
TRADE KIND
SHOWING 87 / 87
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Kim Kelderman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+75.00%-3.13%-0.48%-2.65%-3.48%—
14d8+62.50%-4.66%-0.42%-4.25%-5.74%—
30d8+75.00%-6.02%+0.09%-6.10%-6.20%—
60d8+62.50%-9.22%+0.50%-9.72%-15.52%—
90d8+62.50%-9.67%+0.09%-9.76%-14.08%—
180d8+62.50%-8.30%+2.46%-10.76%-12.40%—
1y8+87.50%-20.00%+0.13%-20.13%-19.98%—
2y8(2 pending)+100.00%-35.63%+2.87%-38.51%-40.30%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TECH · 89,750 shares · as of May 5, 2026
028,93157,86286,793115,724202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 47 buys / 40 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CNMD
CONMED CORP
PURCHASEGRANT
Stock grant
5,772——5,772Jun 1, 2026Jun 3, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
26,692——35,000May 5, 2026May 7, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
23,951$56.68$1.36M65,799May 5, 2026May 7, 2026 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
26,692$47.60$1.27M89,750May 5, 2026May 7, 2026 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
11,344——64,421Apr 22, 2026Apr 24, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
1,363$58.58$79.8K63,058Apr 22, 2026Apr 24, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
11,344——61,692Apr 22, 2026Apr 24, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
36,500——73,036Apr 14, 2026Apr 16, 2026 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
36,500——85,165Apr 14, 2026Apr 16, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
32,088$58.66$1.88M53,077Apr 14, 2026Apr 16, 2026 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
2,303$62.57$144.1K48,665Nov 3, 2025Nov 5, 2025 ↗View →
CNMD
CONMED CORP
PURCHASEGRANT
Stock grant
6,227——6,227Sep 8, 2025Sep 9, 2025 ↗View →
CNMD
CONMED CORP
PURCHASEGRANT
Stock grant
500——500Sep 8, 2025Sep 9, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
90,441——90,441Aug 15, 2025Aug 19, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
8,543——55,273Aug 15, 2025Aug 19, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
35,354——35,354Aug 15, 2025Aug 19, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
4,305$53.60$230.7K50,968Aug 15, 2025Aug 19, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
70,708——70,708Aug 15, 2025Aug 19, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
8,543——17,087Aug 15, 2025Aug 19, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
48,176$44.33$2.14M90,379Jul 22, 2025Jul 24, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
48,176——0Jul 22, 2025Jul 24, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
43,649$53.12$2.32M46,730Jul 22, 2025Jul 24, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
36,132——48,176Jul 15, 2025Jul 17, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
32,933$51.42$1.69M42,203Jul 15, 2025Jul 17, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
36,132$44.33$1.60M75,136Jul 15, 2025Jul 17, 2025 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
13,392$37.70$504.9K52,396Jan 27, 2025Jan 29, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
11,731$77.19$905.5K40,665Jan 27, 2025Jan 29, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
13,392——0Jan 27, 2025Jan 29, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
1,661$77.95$129.5K39,004Jan 27, 2025Jan 29, 2025 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
2,430$75.31$183.0K39,004Nov 1, 2024Nov 5, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
1,492$66.97$99.9K41,434Aug 29, 2024Sep 3, 2024 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
1,492——115,724Aug 29, 2024Sep 3, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
51,261——51,261Aug 15, 2024Aug 19, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
25,630——25,630Aug 15, 2024Aug 19, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
69,061——69,061Aug 15, 2024Aug 19, 2024 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
9,479$81.97$777.0K39,942Jul 31, 2024Aug 2, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Chief Executive Officer
14,000$37.70$527.8K49,421Jul 31, 2024Aug 2, 2024 ↗View →
TECH
BIO-TECHNE CORP
SALE
Chief Executive Officer
14,000——13,392Jul 31, 2024Aug 2, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
9,423——9,423Feb 1, 2024Feb 5, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
25,945——25,945Feb 1, 2024Feb 5, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
51,890——51,890Feb 1, 2024Feb 5, 2024 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
38,252——38,252Nov 1, 2023Nov 3, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
14,196——35,421Nov 1, 2023Nov 3, 2023 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
2,100——109,536Aug 24, 2023Aug 28, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
2,100$47.60$100.0K21,225Aug 24, 2023Aug 28, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
29,391——29,391Aug 15, 2023Aug 17, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
22,043——22,043Aug 15, 2023Aug 17, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
8,191——8,191Aug 15, 2023Aug 17, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
8,873——8,873Aug 15, 2023Dec 14, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
23,881——23,881Aug 15, 2023Dec 14, 2023 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
4,139$82.17$340.1K19,125Aug 5, 2023Aug 8, 2023 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
8,060——0Aug 5, 2023Aug 8, 2023 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
8,060——23,264Aug 5, 2023Aug 8, 2023 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
663——6,848Aug 23, 2022Aug 25, 2022 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
663$150.78$100.0K3,801Aug 23, 2022Aug 25, 2022 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
7,235——7,235Aug 15, 2022Aug 17, 2022 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
1,746——1,746Aug 15, 2022Aug 17, 2022 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
5,426——5,426Aug 15, 2022Aug 17, 2022 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
2,363——4,352Aug 7, 2022Aug 9, 2022 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
1,214$382.97$464.9K3,138Aug 7, 2022Aug 9, 2022 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
2,363——0Aug 7, 2022Aug 9, 2022 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
1,989——7,511Feb 8, 2022Feb 10, 2022 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
1,989$150.78$299.9K1,989Feb 8, 2022Feb 10, 2022 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
100$503.76$50.4K400Nov 19, 2021Nov 23, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
500——2,152Nov 19, 2021Nov 23, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
400$505.78$202.3K0Nov 19, 2021Nov 23, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
500$150.78$75.4K500Nov 19, 2021Nov 23, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
822$529.04$434.9K0Sep 22, 2021Sep 24, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
1,691——0Aug 8, 2021Aug 10, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
1,691——1,691Aug 8, 2021Aug 10, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
869$481.82$418.7K822Aug 8, 2021Aug 10, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
1,245——1,245Aug 6, 2021Aug 10, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
4,864——4,864Aug 6, 2021Aug 10, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
6,486——6,486Aug 6, 2021Aug 10, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
811$433.00$351.2K0Jun 9, 2021Jun 11, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
845$424.00$358.3K811May 25, 2021May 27, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
856$427.49$365.9K1,656May 1, 2021May 4, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
1,667——0May 1, 2021May 4, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
1,667——2,512May 1, 2021May 4, 2021 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
823$388.45$319.7K845Feb 5, 2021Feb 9, 2021 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
8,325——8,325Aug 5, 2020Aug 7, 2020 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
2,015——2,015Aug 5, 2020Aug 7, 2020 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
8,991——8,991Aug 5, 2020Aug 7, 2020 ↗View →
TECH
BIO-TECHNE CORP
PURCHASEGRANT
Stock grant
11,988——11,988Aug 5, 2020Aug 7, 2020 ↗View →
TECH
BIO-TECHNE CORP
PURCHASE
Pres. Diagnostics & Genom
1,666——2,489May 1, 2020May 5, 2020 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
1,666——1,667May 1, 2020May 5, 2020 ↗View →
TECH
BIO-TECHNE CORP
SALE
Pres. Diagnostics & Genom
821$227.54$186.8K1,668May 1, 2020May 5, 2020 ↗View →
Other insiders · TECH
Loading peer insiders…
About this filer
CIK 0001739054
ROLE
Pres. Diagnostics & Genom
PRIMARY
TECH
COMPANIES
2
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001739054DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback